Integra LifeSciences | IART - Operating Expenses


Integra LifeSciences reported $1.04B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
AtriCure USD 143.94M 3.22M Jun/2026
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
CONMED USD 307.08M 15.45M Jun/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Globus Medical USD 595.85M 49.26M Mar/2026
HeartBeam USD 5.31M 20K Dec/2025
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
J&J USD 17.83B 388M Jun/2026
Medtronic USD 7.72B 436M Mar/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Smith & Nephew USD 2.59B 71M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 264.65M 17.43M Mar/2026
Teleflex USD 2.9B 179.9M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026